N/A N=67 Outcomes of Compliance With Brace Wear in Clubfoot
Clubfoot
Primary: Wear Rate Percentage (Number of Hours Per Day Brace Was Worn Out of the Recommended 24 Hours) — 91.7; NA; NA; 86.8 percentage of time worn
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=245 Effect of Compliance Counseling on Brace Success in Patients With Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
Primary: Brace Progress Report (i.e. Informing the Patient How Often They Were Wearing the Brace Versus Not Informing the Patient) — 93; 78; 26; 29 participants
N/A N=20 Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents With Special Needs
Visual Rehabilitation · Visual Impairment, Autism Spectrum Disorder, Developmental Disabilities, Intellectual Disability, Behavioral Symptoms
Primary: Visual Function Battery for Children With Special Needs (VFB-CSN) — 45.00; 48.21 score — p=0.008
N/A N=9 Behavioral Economics and Communication
Problem Behavior
Primary: Averge of Aappropriate Communication Responses — 3.33 direct observation of 5-min sessions
N/A N=375 Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Dyslipidemia
Primary: Percentage of Participants Who Were Compliant With Statin Treatment — 86.7 Percentage of participants
N/A N=60 Smart Capsule for Automatic Adherence Monitoring
Medication Adherence
Primary: Medication Adherence — 88.1; 96.6; 94.4 percentage of doses taken (pill count)
N/A N=53 Investigation of Wearing Compliance of Spectacles for Myopia Control
Myopia
Primary: Overall Wearing Pattern of Myopia Control Spectacles — 12.8 Hours in a day
N/A N=48 Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
Obstructive Sleep Apnea
Primary: Group Compliance of the Auto Bilevel Group Compared to the CPAP Group Measured by Average Nightly Use. — 284.7; 255.1 minutes/night — p=0.377
N/A N=257 Compliance With Treatment For Patients With Hyperlipidemia
Hyperlipidemia
Primary: Percentage of Participants With Positive Response on Increased Motivation Using a Self-test at Month 12 — 36.2 Percentage of participants
N/A N=50 Nexus Compliance Study
Obstructive Sleep Apnea
Primary: Compliance on CPAP — 6.58; 7.07; 6.72 Hours
N/A N=62 Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial
Rheumatic Diseases · Gout · Adherence, Medication
Primary: Rate of Medication Adherence — 0.76; 0.79; 0.83 percentage of doses taken — p=0.78
N/A N=476 Behavioral Economic Strategies to Improve PRO Adherence
Cancer
Primary: PRO Adherence — 50.0; 56.9; 34.9 pct. assigned questionnaires completed
Phase 4 N=262 Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia
Dyspepsia · Compliance · Depression
Primary: Compliance of Flupentixol-Melitracen — 44; 28; 31 participants
N/A N=169 CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence
Adherence
Primary: Nightly Adherence — 4.83; 5.82; 4.82; 4.60 hours
N/A N=14 Nudging Guideline-concordant Antibiotic Prescribing Using Public Commitments
Acute Respiratory Infections (ARIs)
Primary: Inappropriate Antibiotic Prescribing for Patients With Acute Respiratory Infections (ARI) — 33.7; 52.7 inappropriate prescribing events
N/A N=124 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA
Premature Infants
Primary: Number of Injections Per Patient Per Season — 3.8; 3.9; 4.0; 1.0 Injections administered
N/A N=200 Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?
Patient Compliance · Pelvic Floor Disorders
Primary: Number of Participants With Completed PT Visits — 47; 50; 11; 21 Participants — p=0.17
N/A N=201 Social Forces to Improve Statin Adherence (Study B)
Medication Adherence · High Blood Pressure · Diabetes
Primary: Statin Adherence — 79; 84; 80 percentage of correct statin doses
N/A N=153 Non-compliance on Treatment Among Diabetic Students at Sohag University
Diabetes Mellitus, Type 1
Primary: Distribution of Participants Responses as Regards DSMQ Glucose Management Domain — 13; 56; 39; 45 Participants
N/A N=150 Behavioral Contract Adherence Intervention
Renal Transplantation
Primary: Comparison of Average Immunosuppressant Therapy Adherence for 12-month Study Period — 0.88; 0.81 medication possession ratio (proportion) — p=<0.05
N/A N=66 Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation
OCD · Decision-Making · tDCS
Primary: Strength of Behaving Model-based (Goal-directed) — 0.09; 0.07; -0.08; 0.06 units on a scale
N/A N=40 Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
Medication Adherence
Primary: Medication Adherence — 94.8; 82.8 percentage of doses taken
N/A N=72 Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
Smokers
Primary: Percent Compliance With Chantix — 90.7; 85.8; 87.1; 91.7 Percentage of Participants
N/A N=104 Behavioral Economics and Adherence in Teens (BEAT!)
Epilepsy · Adherence, Medication
Primary: Electronically Monitored Adherence — 45.5; 50.5 units on a scale — p=0.002
N/A N=60 Behavioral Economics to Improve Antihypertensive Therapy Adherence
Hypertension · Medication Adherence
Primary: Electronically Measured Mean Medication Adherence During Intervention — 87; 95; 92 Percentage of Timely Med Adherence
Phase 4 N=154 Self-management of Low Molecular Weight Heparin Therapy
Thromboembolism
Primary: Drug Use Problems — 1.25; 0.86; 1.20; 1.17 scores on a scale
N/A N=19 Technology-Enhanced Helping the Noncompliant Child
Child Externalizing Behavior
Primary: Retention — 8; 7 Participants
N/A N=50 Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients
Colorectal Cancer (CRC)
Primary: Number of Participants Who Maintained an Exercise Regimen Average of 18 Metabolic Units (MET) Per Week or Greater — 18 participants
Phase 4 N=197 Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy
Chronic Hepatitis C · Genotype 1
Primary: Treatment Duration Compliance Rate — 85.4; 83.8 Percentage of compliance — p=0.4864
N/A N=155 Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens
Type 1 Diabetes
Primary: Change in Glycated Hemoglobin- HbA1c — -0.14; -0.09 Change in A1c (%)